Search

Learn how bladder removal to treat bladder cancer can be effective without impairing quality of life.

Memorial Sloan Kettering and the City College of New York (CCNY) were recently awarded a $4 million grant from the National Institutes of Health to study the use of machine learning for early breast cancer detection in high-risk women.

Learn the truth behind common misunderstandings about breast reconstruction.

New research from the Craig Thompson Lab offers a closer look at the transcriptional activators, Yap/Taz, and the role they play in cell growth and macropinocytosis.

Six young scientists at Memorial Sloan Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College have been named the inaugural winners of a new prize established to recognize postdoctoral investigators in the life sciences. The Tri-Institutional Breakout Awards for Junior Investigators, which include a $25,000 prize for each recipient, were established by three Tri-Institutional winners of the 2013 Breakthrough Prize in Life Science — one from each of the three institutions — with additional financial support from the institutions themselves.

The June 15 edition of “MSK Science Spotlight,” features Derek Tan, PhD discussing “A Drug Discovery Journey from Tuberculosis to Cancer.”

In a world where one in every two people will be diagnosed with cancer in their lifetime, the Publicis Foundation is launching the first cross-industry coalition to erase the stigma of cancer in the workplace, supported by leading cancer charities and organizations including Memorial Sloan Kettering Cancer Center (MSK), MacMillan Cancer Support and the Gustave Roussy Institute.

An MSK study explains how the drug selinexor, which was recently approved to treat multiple myeloma and is being tested in many other tumor types, stops cancer.